Latest

The Infrastructure Layer for AI-Mediated Purchase Decisions 58% of buyers now use AI systems to choose between competing brands. Not to research. Not to browse. To choose. “Which CRM should we buy?” “Book me a hotel in Paris.” “What’s the best anti-aging serum?” AI systems are answering

Digital leaders have spent two decades optimizing for visibility. Rank position. Click-through rate. Conversion rate. Share of search. But AI assistants are introducing a structural shift. They do not distribute attention across ranked links. They compress category decisions into a single recommendation. That compression changes competitive dynamics. Presence Is

If an AI assistant generates a materially adverse or misleading representation of your institution today… Could you reconstruct it six months from now? Precisely. • Exact prompt • Exact model and version • Exact output • Exact timestamp • Demonstrable testing conditions Or would you rely on screenshots and internal recollection? In controlled testing, we

When the U.S. Food and Drug Administration formalized its risk-based credibility framework for AI in healthcare, commentary focused on compliance cost and innovation friction. That interpretation understates the shift. The FDA normalized AI as regulated decision infrastructure. Once AI is treated as infrastructure, accountability expands beyond what an

A new variable is entering forecast models. It is not yet measured. In most institutions, revenue forecasting rests on a stable identity: Expected Revenue = Pipeline Volume × Win Probability × Average Deal Value Pipeline is tracked. Deal value is modeled. Win probability is stress-tested. What is rarely examined is whether the

1. The Evidence Is No Longer Theoretical Under controlled, repeatable prompt classes across major AI systems: * Institutional ordering diverges * Narrative framing shifts under identical queries * Final recommendation resolution varies by model * Displacement patterns remain stable within execution windows This is not anecdotal. It is observable and reproducible. The phenomenon exists.

Abstract Where Case Study 1 documented platform-dependent divergence in oncology, this case documents cross-platform convergence in cardiology. Under identical decision-stage prompts, multiple AI systems consistently positioned the same therapy as preferred. The relevance lies not in clinical deviation, but in authority formation and the visibility of its